Peter Mac’s Associate Professor Belinda Campbell will use a new fellowship to find practical solutions to improve equity of care for patients with cutaneous T-cell lymphomas – no matter where they live in Australia.
Researchers have developed a new blood test that could revolutionise how chemotherapy is used for colon cancer, by identifying the patients that need chemo and those that can be safely spared treatment.
Peter Mac’s Associate Professor Michael Dickinson has presented new data from a trial of the investigational blood cancer drug Glofitamab, at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago overnight.
Peter Mac and the VCCC Alliance will soon be launching the Implementation Science in Cancer program. We talk to Senior Research Lead – Implementation Science Associate Professor Stephanie Best on the field in general and what the program seeks to achieve.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.